<DOC>
	<DOC>NCT00832390</DOC>
	<brief_summary>After 24 weeks of treatment evaluate the efficacy and security.</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients Being Treated With Metformin Patients With Hba1c Between 6.5 % And 12.0%. Type 2 DM</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>